Can Mounjaro cause changes to your periods?

Does Mounjaro directly affect your hormones?

The short answer is that tirzepatide (the medicine inside every Mounjaro KwikPen) acts on two gut-hormone receptors (GIP and GLP-1) involved in appetite regulation and blood-sugar control. These receptors are not part of the reproductive hormone pathway in the way that, say, hormonal contraception is. The NHS tirzepatide information page does not list menstrual disruption as a recognised side effect of the drug itself.

What it does list (nausea, reduced appetite, significant weight loss) matters enormously for the menstrual cycle, because body fat is an active site of oestrogen production. When fat mass drops quickly, oestrogen levels can shift, and the hypothalamic-pituitary-ovarian axis (the chain of hormonal signals that drives ovulation) is sensitive to those shifts. This is the same reason that rapid weight loss through any route, whether surgery, a very low-calorie diet, or a medicine, can cause cycles to become irregular.

So the relationship is real, but indirect. Mounjaro creates conditions in which period changes become more likely; it is not acting on the uterus or ovaries directly. For a fuller picture of how tirzepatide works in the body, the tirzepatide overview covers the mechanism in more detail.

What kinds of period changes have been reported?

Women on Mounjaro have reported a range of menstrual changes, and the pattern largely mirrors what the medical literature shows with other forms of significant weight loss. Cycles can become shorter or longer, flow can lighten or, for some women, become heavier during early weight loss as stored oestrogen is mobilised from fat tissue. Some women experience missed periods, particularly if weight loss is rapid in the first months of treatment.

There is also a subset of women, particularly those with polycystic ovary syndrome (PCOS), for whom weight loss actually restores more regular cycles. Insulin resistance plays a central role in PCOS-related menstrual irregularity, and tirzepatide's effect on insulin signalling may, indirectly, support more predictable ovulation in this group. This is an active area of clinical interest rather than a licensed indication, so it should not be treated as a guaranteed outcome, discuss it specifically with your prescriber.

A more detailed look at this topic, including what the evidence says about both lighter and heavier flow, is on the pages covering whether Mounjaro can stop periods and whether it can cause heavier periods, both worth reading if your experience leans in one direction.

What should you do about contraception while on Mounjaro?

This is the practical question that matters most. NHS guidance is clear: women taking oral contraceptive pills should use an additional, non-oral method of contraception (condoms, for instance) for the first four weeks of starting Mounjaro and for four weeks after every dose increase. The reason is that Mounjaro slows gastric emptying, which can reduce how much of a swallowed pill is absorbed from the gut. There is no equivalent evidence of this effect for semaglutide (the active ingredient in Wegovy), but for tirzepatide the precaution is supported by NHS England's guidance on weight-management injections.

If you use a non-oral method already (a patch, implant, hormonal coil, or injection), you do not need to make any additional changes on this basis. But if you rely solely on a daily pill, this is worth reviewing with your prescriber before your first pen arrives, not something to sort out after the fact. You can read more on the specific topic of how Mounjaro may affect periods and pill absorption on a dedicated page.

On the broader question of cost and what private treatment involves, the Mounjaro pricing page explains what a legitimate prescription includes and how to compare providers sensibly.

When should a period change prompt a call to your GP?

Most cycle changes in the early months of treatment settle once weight loss stabilises. A missed period or two, or a shift in flow, is common and not usually a sign that something is wrong. That said, some changes deserve prompt attention. If you experience very heavy bleeding that soaks through protection quickly, severe pelvic pain, or a period that has simply not returned after three or four months, speak to your GP rather than assuming it is treatment-related.

Pregnancy is also worth considering: Mounjaro is not recommended in pregnancy, and the contraception precautions above matter partly for this reason. If there is any chance you could be pregnant, take a test. Mounjaro should be stopped, and your prescriber contacted. If you are thinking about trying to conceive, this is a conversation to have with your clinical team before you stop or continue treatment. Our clinical team can discuss these questions during your consultation, and our FAQs cover some of the broader questions patients ask about treatment and reproductive health.

If you have questions or would like to discuss how Mounjaro might fit your circumstances, check your eligibility through a free consultation with one of our GPhC-registered prescribers.